<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107571">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01896063</url>
  </required_header>
  <id_info>
    <org_study_id>wangqiang888</org_study_id>
    <nct_id>NCT01896063</nct_id>
  </id_info>
  <brief_title>Sedative and Hypnotic Effects Induced by EA</brief_title>
  <official_title>EA Induces Sedative and Hypnotic Effects by Detecting BIS Value and MRI.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insomnia is a common clinical disease.The serious patients could not sleep all night, often
      accompanied by headache, dizziness, forgetfulness and so on. All of these increase the
      mental burden of insomnia patients and seriously affected the normal work and quality of
      life of patients. Modern medical treatment to treat insomnia is using sedative and hypnotic
      drugs, mainly benzodiazepine, zopiclone. But long-term use of these drugs can induce the
      adverse reactions, including resistance, dependence and addiction. Many articles indicate
      that electroacupuncture can effectively improve insomnia, play the role of sedative and
      hypnotic effect and avoid many adverse reactions and side effects. Then there are no more
      objective indicators to affirm that which part of brain takes place the appropriate changes
      when electroacupuncture induces the sedative effect. So we designed this experiment.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>BIS value</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome is assessing whether BIS value reduce during electroacupuncture stimulation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Bypass Complications</condition>
  <arm_group>
    <arm_group_label>Electroacupuncture preconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electroacupuncture</intervention_name>
    <arm_group_label>Electroacupuncture preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be able to go with EA

          -  Can not have any disease

        Exclusion Criteria:

          -  Overworked recently
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Wang, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 7, 2013</lastchanged_date>
  <firstreceived_date>January 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital</investigator_affiliation>
    <investigator_full_name>wangqiang</investigator_full_name>
    <investigator_title>department of anesthesijology</investigator_title>
  </responsible_party>
  <keyword>EA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypnotics and Sedatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
